TechSeeker Profile

Apexigen Inc
Profile last edited on: 3/17/2022

Clinical-stage biopharmaceutical company
TS Type
Small Corp
Status
N/A
Year Founded
2010
Last Involved Year
2010

Key People / Management

  Xiaodong Yang -- President & CEO

Location Information

75 Shoreway Road Suite C
San Carlos, CA 94070
   (650) 931-6236
   www.apexigen.com

Public Profile

Apexigen is a clinical-stage biopharmaceutical company focusing on the discoveryand development of innovative antibody-based therapeutics for the treatment of cancerwith a focus on immuno-oncology. The company’s pipeline of immuno-oncology therapeuticcandidates is led by sotigalimab, which is currently in clinical development, andalso includes several preclinical stage immune-oncology programs. Apexigen’s APXiMAB™ technology platform enablesApexigen and its partners to discover high-quality antibody drug candidates againstchallenging disease targets. Apexigen has established multiple corporate partnerships:five of these partners are conducting clinical trials of antibodies discovered throughthe use of the APXiMAB™ platform.

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Headquartered
USA
Employment
35
Revenue
N/A
Public/Private
Privately Held
Stock Info
----
Received SBIR $$
No

Techseeker firm in the news

There are no news available.